| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.39 | 0.003 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.006 |